US$ 25.98
retatrutide clinical trial status Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care A New Obesity Drug Delivered
Description
Interestingly, in both studies this ability to reduce alcohol consumption seems to be dependent on the baseline consumption levels

GIP (glucose-dependent insulinotropic polypeptide): This is the second pathway targeted by tirzepatide (Zepbound, Mounjaro)

At 10mg/mL, a 2mg dose is 20 units

Essential Extras: This medication is administered once daily

For compounded alternatives, pricing varies by pharmacy, formulation, dose, program structure, and included provider support